Syngenis joins WA research heavyweights in RNA medicine push
Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.
We haven't written up this one. The Sydney Morning Herald has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.